Depression and anxiety disorders in chronic obstructive pulmonary disease patients: Prevalence, disease impact, treatment

World J Psychiatry. 2024 Dec 19;14(12):1797-1803. doi: 10.5498/wjp.v14.i12.1797.

Abstract

Chronic obstructive pulmonary disease (COPD) is a common respiratory disorder that often co-occurs with depression and anxiety, worsening disease progression and reducing quality of life. A thorough review of the existing literature was conducted, including searches in PubMed, Embase, PsycINFO, and Cochrane Library databases up to 2024. This review encompasses a critical analysis of studies reporting on the prevalence, impact, and management of depression and anxiety in COPD patients. We found a high prevalence of psychological comorbidities in COPD patients, which were associated with worse disease outcomes, including increased exacerbations, hospitalizations, and reduced health-related quality of life. Diagnosing and managing these conditions is complex due to overlapping symptoms, necessitating a comprehensive patient care approach. While there has been progress in understanding COPD comorbidities, there is a need for more personalized and integrated treatments. This review emphasizes the need for increased awareness, tailored treatment plans, and further research for effective interventions.

Keywords: Anxiety; Chronic obstructive pulmonary disease; Comorbidities; Depression; Narrative review; Treatment strategies.

Publication types

  • Review